Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience
-
Published:2024-06-03
Issue:
Volume:14
Page:
-
ISSN:2234-943X
-
Container-title:Frontiers in Oncology
-
language:
-
Short-container-title:Front. Oncol.
Author:
Yan Ningning,Guo Sanxing,Huang Siyuan,Zhang Huixian,Li Xingya
Publisher
Frontiers Media SA